Appendix III to the qrd templates for human medicinal products

3 February 2016

EMEA/29277/2003 v.4

Human Medicines Evaluation Division

Appendix III to the QRD templates for human medicinal products

This appendix should be read together with the Note for Guidance on the Declaration of Storage Conditions A) in the product information of medicinal products, and B) for active substances (EMEA/CPMP/QWP/609/96/Rev 2).

The purpose of the Note for Guidance is to set out uniform statements on storage conditions for inclusion in the product information of medicinal products and labelling of active substances and to define when they apply. The CHMP adopted a revision of this document in November 2007, which resulted in amendments of/or additions to the required storage statements.

Storage Conditions
BG Bulgaria	IT Italian
CS Czech	LT Lithuanian
DA Danish	LV Latvian
DE German	MT Maltese
EL Greek	NL Dutch
EN English	NO Norwegian
ES Spanish	PL Polish
ET Estonian	PT Portuguese
FI Finnish	RO Romania
FR French	SK Slovak
HR Croatian	SL Slovenian
HU Hungarian	SV Swedish
IS Icelandic

30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom

An agency of the European Union

Telephone

[phone]

Facsimile

[phone]

Send a question via our website www.ema.europa.eu/contact

© European Medicines Agency, 2018. Reproduction is authorised provided the source is acknowledged.